Department of Health and Human Services
National Institutes of Health
Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial ( printed page 12330) property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; National Institute of Diabetes and Digestive and Kidney Diseases Small Business Innovation Research/Small Business Technology Transfer Special Emphasis Panel.
Date: April 1-2, 2025.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Democracy II, Suite 7000A, 6707 Democracy Boulevard, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Cheryl Nordstrom, Ph.D., MPH, Scientific Review Officer, Scientific Review Branch, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 6707 Democracy Blvd., Room 7013, Bethesda, MD 20892, 301-402-6711, cheryl.nordstrom@nih.gov.
Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; RC2 Review.
Date: April 8, 2025.
Time: 10:30 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Democracy II, Suite 7000A, 6707 Democracy Boulevard, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Ann Jerkins, Ph.D., Scientific Review Officer, Review Branch, Division of Extramural Research, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Room 7119, Bethesda, MD 20892, 301-594-2242, jerkinsa@niddk.nih.gov.
Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; Small Business Innovation Research Special Emphasis Panel.
Date: April 9-10, 2025.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Democracy II, Suite 7000A, 6707 Democracy Boulevard, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Michele Barnard, Ph.D., Scientific Review Officer, Review Branch, Division of Extramural Research, National Institutes of Health,National Institute of Diabetes and Digestive and Kidney Diseases, Room 7353, Bethesda, MD 20892, (301) 594-8898, barnardm@extra.niddk.nih.gov.
Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; Small Business Innovation Research.
Date: April 24-25, 2025.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Democracy II, Suite 7000A, 6707 Democracy Boulevard, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Ann Jerkins, Ph.D., Scientific Review Officer, Review Branch, Division of Extramural Research, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Room 7119, Bethesda, MD 20892, 301-594-2242, jerkinsa@niddk.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS)
Dated: March 12, 2025.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.